And that's a wrap from Day 2 at #HHTSciCon. Our second day in France began with an overview of Diagonal Therapeutics' novel antibody therapy that as the potential to reverse disease at the biologic level and concluded with a "pros & cons" debate session on contentious HHT topics... with plenty of meaningful science and research in between. The future of HHT treatment is bright thanks to the brilliant minds present at this meeting.
-
+3